Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC
ecancermedicalscience · 09.03.2026 · 20
DOI: 10.3332/ecancer.2026.2086 ↗Kurz gefasst
Fachartikel in der Zeitschrift ecancermedicalscience, online erschienen am 09.03.2026. Verfasst von Sree Siva Kumar Raja Addagalla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai 400094, India. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
- https://orcid.org/0009-0009-0042-8609.
- https://orcid.org/0000-0002-4214-5799.
- https://orcid.org/0009-0004-3769-3194.
- https://orcid.org/0000-0001-8858-5004.
Zitieren
APA
Addagalla, S. S. K. R., Noronha, V., Menon, N., Shah, M., Joshi, A., Shah, A., & Prabhash, K. (2026). Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC. ecancermedicalscience, 20. https://doi.org/10.3332/ecancer.2026.2086
Vancouver
Addagalla SSKR, Noronha V, Menon N, Shah M, Joshi A, Shah A, et al. Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC. ecancermedicalscience. 2026;20. doi:10.3332/ecancer.2026.2086
BibTeX
@article{Addagalla2026,
author = {Addagalla, Sree Siva Kumar Raja and Noronha, Vanita and Menon, Nandini and Shah, Minit and Joshi, Amit and Shah, Anokhi and Prabhash, Kumar},
title = {Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC},
journal = {ecancermedicalscience},
year = {2026},
volume = {20},
doi = {10.3332/ecancer.2026.2086}
}
EUVIMED